Cormorant Asset Management, LP, 10% Owner, Director at Biomea Fusion, Inc. (BMEA), bought 3,170,872 shares at $17.00 ($15.3M) on 2021-04-20, disclosed to the SEC on 2021-04-22.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 2,270,872 | $0 | 0.0% |
| 2 | $17.00 | 900,000 | $15.3M | 100.0% |
| Total | $4.83 avg | 3,170,872 | $15.3M | 100% |
| Filing → |
| DRUG | BUY | 2024-11-06 | $8.0M | — | Filing → |
| EYPT | BUY | 2024-05-08 | $20.2M | — | Filing → |
| CRBP | BUY | 2024-02-06 | $14.3M | — | Filing → |